StemX Bio

StemX Bio is at the forefront of biotechnology research, dedicated to revolutionizing drug discovery through cutting-edge human pancreas microtissue models. StemX Bio's innovative, ready-to-use microtissues are designed to empower researchers, accelerating the transition from initial screening to successful clinical trials. Leveraging a patent-pending differentiation protocol, StemX Bio ensures unparalleled predictive value, robustness, and scalability in its models.

Located in Leiden, 2317HH, NL, StemX Bio specializes in the development of advanced 3D in vitro models that closely mimic human physiology. This commitment allows for the creation of safer and more effective therapies, particularly for diabetes. StemX Bio is dedicated to shaping the future of medical research, driving innovation, and fostering significant advancements in treatment options.

With its focus on cell-based assays, spheroids, and islet biology, StemX Bio is rapidly becoming a key player in the biotechnology landscape. By choosing StemX Bio, researchers gain access to state-of-the-art tools and technologies designed to enhance drug development and accelerate the discovery process. We invite the StemX Bio management team to create a customized and exclusive company showcase and product listing on our platform, further highlighting your groundbreaking work.